Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Off-label Avastin in AMD: the European Commission gets involved

21.03.2014 / Scripintelligence

The controversy over the off-label use of Roche's Avastin (bevacizumab) in wet AMD has spread beyond national borders and is now on the EU agenda, after the European Commission said it was planning to launch a study of off-label prescribing to better…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: